These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31483658)

  • 21. Drugs and lipid metabolism.
    Truswell AS
    Proc Nutr Soc; 1974 Dec; 33(3):215-24. PubMed ID: 4459966
    [No Abstract]   [Full Text] [Related]  

  • 22. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioactive Dietary Fibers Selectively Promote Gut Microbiota to Exert Antidiabetic Effects.
    Nie Q; Hu J; Gao H; Li M; Sun Y; Chen H; Zuo S; Fang Q; Huang X; Yin J; Nie S
    J Agric Food Chem; 2021 Jun; 69(25):7000-7015. PubMed ID: 34139119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The clinical biochemistry of hyperlipemia and hyperglycemia. Insulin and metabolism of fatty acids. Hypoglycemic effect of hyperlipemicpharmaceuticals].
    Titov VN; Rozhkova TA; Ameliushkina VA
    Klin Lab Diagn; 2014 Mar; (3):4-13. PubMed ID: 25080782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.
    Wang Y; Deng GG; Davies KP
    Am J Physiol Endocrinol Metab; 2016 Aug; 311(2):E471-9. PubMed ID: 27354236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
    Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
    Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia.
    Tazuma S; Yamashita G; Ochi H; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Kajiyama G
    Clin Ther; 1998; 20(3):477-85. PubMed ID: 9663363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy.
    Lindsay KL; Hellmuth C; Uhl O; Buss C; Wadhwa PD; Koletzko B; Entringer S
    PLoS One; 2015; 10(12):e0145794. PubMed ID: 26716698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients.
    Bajaj M; Suraamornkul S; Romanelli A; Cline GW; Mandarino LJ; Shulman GI; DeFronzo RA
    Diabetes; 2005 Nov; 54(11):3148-53. PubMed ID: 16249438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of a sustained-release preparation of acipimox on dyslipidemia and glucose metabolism in non-insulin-dependent diabetes mellitus.
    Davoren PM; Kelly W; Gries FA; Hubinger A; Whately-Smith C; Alberti KG
    Metabolism; 1998 Mar; 47(3):250-6. PubMed ID: 9500558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous cortisol excess confers a unique lipid signature and metabolic network.
    Vega-Beyhart A; Iruarrizaga M; Pané A; García-Eguren G; Giró O; Boswell L; Aranda G; Flores V; Casals G; Alonso C; Mora M; Halperin I; Carmona F; Enseñat J; Vidal O; Hu T; Rojo G; Gomis R; Hanzu FA
    J Mol Med (Berl); 2021 Aug; 99(8):1085-1099. PubMed ID: 33881561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma Metabolomics and Lipidomics Differentiate Obese Individuals by Peripheral Neuropathy Status.
    Guo K; Savelieff MG; Rumora AE; Alakwaa FM; Callaghan BC; Hur J; Feldman EL
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1091-1109. PubMed ID: 34878536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary Metabolomics Study on the Protective Role of Cocoa in Zucker Diabetic Rats via
    Fernández-Millán E; Ramos S; Álvarez-Cilleros D; Samino S; Amigó N; Correig X; Chagoyen M; Álvarez C; Martín MÁ
    Nutrients; 2022 Oct; 14(19):. PubMed ID: 36235779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of lipid profiles of type 2 diabetes associated with hyperlipidemia using untargeted UPLC Q-TOF/MS-based lipidomics approach.
    Yan L; Han P; Man J; Tian Y; Wang F; Wang J
    Clin Chim Acta; 2021 Sep; 520():53-62. PubMed ID: 34077755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diminished retinal complex lipid synthesis and impaired fatty acid β-oxidation associated with human diabetic retinopathy.
    Fort PE; Rajendiran TM; Soni T; Byun J; Shan Y; Looker HC; Nelson RG; Kretzler M; Michailidis G; Roger JE; Gardner TW; Abcouwer SF; Pennathur S; Afshinnia F
    JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34437304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin.
    Nunez DJ; Yao X; Lin J; Walker A; Zuo P; Webster L; Krug-Gourley S; Zamek-Gliszczynski MJ; Gillmor DS; Johnson SL
    Diabetes Obes Metab; 2016 Jul; 18(7):654-62. PubMed ID: 26939572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Untargeted Multiomics Approach Coupling Lipidomics and Metabolomics Profiling Reveals New Insights in Diabetic Retinopathy.
    Ancel P; Martin JC; Doukbi E; Houssays M; Gascon P; Righini M; Matonti F; Svilar L; Valmori M; Tardivel C; Venteclef N; Julla JB; Gautier JF; Resseguier N; Dutour A; Gaborit B
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Metabolism and Medium-Chain Fatty Acid Alterations Precede Long-Chain Fatty Acid Changes Impacting Neutral Lipid Metabolism in Response to an Anticancer Lysophosphatidylcholine Analogue in Yeast.
    Tambellini NP; Zaremberg V; Krishnaiah S; Turner RJ; Weljie AM
    J Proteome Res; 2017 Oct; 16(10):3741-3752. PubMed ID: 28849941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chikusetsu saponin IVa regulates glucose uptake and fatty acid oxidation: implications in antihyperglycemic and hypolipidemic effects.
    Li Y; Zhang T; Cui J; Jia N; Wu Y; Xi M; Wen A
    J Pharm Pharmacol; 2015 Jul; 67(7):997-1007. PubMed ID: 25677570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.